SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Abgenix, Inc. (ABGX) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (272)10/17/2003 2:14:49 AM
From: mopgcw  Respond to of 590
 
interesting juxtaposition. Some say it is better to be a fast follower than a pioneer. thanks.



To: Miljenko Zuanic who wrote (272)10/17/2003 3:43:17 AM
From: nigel bates  Read Replies (1) | Respond to of 590
 
AZ bit late in decision making

I was interested by the comment that they have targets which are 'non-druggable' with small molecules. Is this something that would only recently have become apparent ?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News